THOMAS TEDESCHI: Open Payments
NPI 1114551371 · JOHNSTON, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,275 in 55 payments from 16 companies in 2025. Trend: 2023 $416 · 2024 $767 · 2025 $1,275
Food & beverage: $1,240Education: $35
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 10 | $201 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $151 |
| Endo USA, Inc. | 4 | $117 |
| ABBVIE INC. | 5 | $116 |
| TOLMAR, INC. | 5 | $111 |
| Ferring Pharmaceuticals Inc. | 5 | $97 |
| Astellas Pharma US Inc | 3 | $78 |
| Blue Earth Diagnostics | 3 | $76 |
| Dendreon Pharmaceuticals LLC | 3 | $67 |
| Teleflex LLC | 2 | $60 |
Products named: Nubeqa, GEMTESA, LUPRON DEPOT, ADSTILADRIN, XIAFLEX, JATENZO, POSLUMA, PROVENGE.
Industry payments across RI — which companies pay providers there.
